Alexander KarpAlexander Karp earned $1B in 2024

In 2017, Jeffrey T. Slovin earned $11.11M in total compensation at DENTSPLY SIRONA, including $727.62K salary and $8.88M in stock. Most recently acquired 205 shares in Jul 2017. Currently holds stock worth $8.63M. Led DENTSPLY SIRONA as CEO for 4 years.

Compensation History

Annual executive compensation data for Jeffrey T. Slovin, including salary, bonuses, and stock awards.

Year

2017

Total Compensation

$11.11M

Salary

$727.62K

Bonus

$0.00

Other

$1.51M

Salary

$727.62K

Board Justification

The compensation philosophy aligns executive compensation with corporate performance and stockholder interests, focusing on attracting and retaining key executives while balancing risk and reward.

Bonus

$0.00

Board Justification

No bonus was awarded for the year 2017 as he resigned before the end of the fiscal year.

Other Compensation

$1.51M

Board Justification

This includes severance payments and other benefits upon resignation.

Restricted Stock

$8.88M133.81K RSU

Board Justification

133,814 shares of restricted stock units vested in 2017, valued at $8,878,738 based on the closing stock price on the vesting date.

Performance Metrics

The performance metrics for 2017 included internal sales growth and non-GAAP net income.

D

Jeffrey T. Slovin

Ex-CEO of DENTSPLY SIRONA

Sector of Economy

Healthcare

CEO of DENTSPLY SIRONA for

4 years 7 months (Feb 2013 - Sep 2017)

Previous Experience

Unknown

Holdings

Track Jeffrey T. Slovin's stock holdings and portfolio value over time.

Insider Trading

Jeffrey T. Slovin's recent stock transactions, purchases, and sales filed with the SEC.

XRAY

204.807 shares

XRAY

Jul 14, 2017

Received

XRAY

212.384 shares

XRAY

Apr 14, 2017

Received

XRAY

23,171 shares

XRAY

Feb 22, 2017

Received

XRAY

178.646 shares

XRAY

Jan 13, 2017

Received

XRAY

284.062 shares

XRAY

Oct 14, 2016

Received

XRAY

278,365 shares

XRAY

Jul 8, 2016

Received

XRAY

789,993 shares

XRAY

Feb 29, 2016

Received

XRAY

544 shares

XRAY

Feb 29, 2016

Received

XRAY

789,993 shares

XRAY

Feb 29, 2016

Received

Rivals

Compare Jeffrey T. Slovin with competitor CEOs and industry peers.